Spots Global Cancer Trial Database for A Novel Treatment for Metastatic Melanoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Novel Treatment for Metastatic Melanoma
Official Title: In Situ Photoimmunotherapy: A Tumor Directed Treatment for Advanced Melanoma With Cutaneous Metastases
Study ID: NCT00758797
Conditions
Interventions
Study Description
Brief Summary: A novel treatment for metastatic melanoma combining a laser and an immune-system stimulating cream.
Detailed Description: A novel treatment for metastatic melanoma combining a laser and an immune-system stimulating cream with or without injection of a substance that makes the tumor more sensitive to the laser.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States
Contact Details
Name: Murad Alam, MD
Affiliation: Northwestern University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
